If you have ever watched a dog get old, you know the particular kind of grief that starts long before the loss. The years go fast. For large breeds, faster still. Most of us accept this as a fixed fact of having a dog. This is just how it works, and you make peace with it.
The Daily Dog earns commissions from qualifying purchases through affiliate links. We only recommend products we have personally used with Hazel or Kaia and clearly note what has helped them.
That assumption is starting to crack. Not because of wishful thinking, but because of actual drug development happening right now, with FDA filings, clinical trials, and new research that connects gut health to cancer survival in dogs. The science of dog aging has become a real field with real funding behind it. What used to be fringe is becoming mainstream veterinary medicine.
Here is what is actually happening and what it means for your dog today.
Why Big Dogs Age Faster: The IGF-1 Problem
The size-lifespan tradeoff in dogs is one of the strangest things in biology. Larger animals generally live longer than smaller ones. Elephants outlive mice. But in dogs, the opposite is true within the species. Great Danes live 8-10 years. Chihuahuas often reach 15+. A dog’s size predicts its lifespan better than almost any other factor.
One leading explanation involves IGF-1, or insulin-like growth factor 1. Large dogs have higher circulating levels of IGF-1. During puppyhood, IGF-1 drives the rapid growth that turns a Great Dane from a puppy to a 150-pound dog in under two years. The problem is that IGF-1 keeps circulating in adulthood, and high levels are associated with accelerated aging at the cellular level. The same mechanism that makes big dogs grow fast may also make them age fast.
The research supporting this link is growing, though scientists are still working out exactly how IGF-1 interacts with other aging pathways. What is clear is that the connection between growth signaling and lifespan in dogs has become a major focus of longevity research.
Loyal: The Company Building Dog Longevity Drugs
Loyal was founded by Celine Halioua with one specific goal: extend the healthy lifespan of dogs. Not just treat disease, but slow aging itself. The company now has multiple drugs in development, and 2026 has brought real regulatory progress.
LOY-002 is Loyal’s most advanced publicly described program. It is a daily flavored tablet designed for dogs aged 10 and older, weighing at least 14 pounds. That broad weight range is a key differentiator. This is not just a large-breed drug. It covers nearly all sizes. LOY-002 works as a caloric restriction mimetic, delivering the biological benefits associated with caloric restriction through a drug, without causing weight loss or appetite suppression. It targets age-associated metabolic dysfunction.
The clinical trial behind LOY-002, called STAY, enrolled its first dog in December 2023. According to Loyal, enrollment completed in July 2025 with 1,300 dogs across 70 veterinary clinics, making it one of the largest veterinary clinical trials ever publicly reported by a company. In January 2026, the FDA accepted the Target Animal Safety (TAS) technical section as part of LOY-002’s Expanded Conditional Approval (XCA) pathway, as publicly reported by Loyal. That is one of three required technical sections for XCA market launch.
LOY-001 is a quarterly injection that targets IGF-1, designed specifically for large and giant breed dogs. The FDA’s Center for Veterinary Medicine recognized a “reasonable expectation of effectiveness” for LOY-001 back in 2023, which is a meaningful regulatory step. It is behind LOY-002 in the approval process.
LOY-003 targets dogs aged 5 years and older, weighing at least 60 pounds. It is also behind LOY-002 in development.
None of these drugs are available yet. That is worth repeating. They are in active development and regulatory review. Loyal is pursuing the FDA’s Expanded Conditional Approval pathway, which is a faster route than the standard process, but it still requires meeting specific safety and effectiveness thresholds before any dog owner can access them.
What the FDA Milestone Actually Means
The FDA’s Expanded Conditional Approval (XCA) pathway for veterinary drugs allows products with a “reasonable expectation of effectiveness” to move toward market while long-term studies continue. XCA is not full approval. It is a time-limited marketing authorization that requires the manufacturer to continue collecting effectiveness data after launch.
For LOY-002, the FDA accepted the Target Animal Safety technical section in January 2026. That is one of three required technical sections for XCA. It means the FDA reviewed the safety data and found it sufficient to keep the process moving forward.
It does not mean the drug works. It does not mean it is approved. It does not mean it is coming to your vet next month.
What it does mean is that Loyal has cleared a real regulatory hurdle that many drug candidates never reach. The term “reasonable expectation of effectiveness” is deliberately distinct from proven effectiveness. The FDA is saying the early data is promising enough to continue, not that the science is settled.
There is no confirmed timeline for when any of Loyal’s drugs will reach the market. The regulatory process is moving forward, and that is genuinely significant. But predicting specific dates would be speculation.
Rapamycin: A Drug Being Studied and Prescribed Off-Label
While Loyal’s drugs are still in development, there is a drug already generating serious interest in veterinary longevity circles: rapamycin.
Rapamycin is a human medication approved for preventing organ rejection in transplant patients and treating certain cancers. It is not FDA-approved for longevity use in dogs. When used in dogs, it is prescribed off-label under veterinary supervision. It works on the mTOR pathway, a cellular signaling system that regulates growth, metabolism, and aging. When mTOR is dialed down, cells slow certain processes associated with aging. In animal models, rapamycin has consistently extended lifespan. In dogs, early results are promising.
The Dog Aging Project (DAP), a large academic research collaboration involving multiple universities, has enrolled over 50,000 dogs in its broader observational study, tracking health data and aging patterns across the general dog population. Within that effort, the TRIAD clinical trial is the most rigorous study of rapamycin in dogs to date. TRIAD has enrolled approximately 180 dogs toward a reported target of 580, based on publicly available trial information. Early data from smaller predecessor studies showed improvements in heart function in older dogs. Full results from the larger trial are pending.
Some veterinarians do prescribe rapamycin off-label for healthy senior dogs in select cases, based on the existing research. It is not a casual supplement and is not appropriate for every dog. Dogs with immune compromise, active infection, or certain cancers or conditions may not be candidates. Rapamycin has real potential side effects including immune suppression, and it requires individualized risk assessment, baseline bloodwork, and ongoing monitoring by a licensed veterinarian. Do not attempt to source rapamycin online or through non-veterinary channels. If a compounded version is used, it should come from a reputable veterinary compounding pharmacy under direct veterinary guidance, as quality can vary. This is a conversation to have with your veterinarian, not something to pursue on your own.
If you have a senior dog and longevity is something you are thinking about, ask your vet whether any longevity research, including the rapamycin trials, is relevant for your dog’s age, breed, and health status. The science is real, and the conversation is worth having.
The Gut Microbiome: The Newest Piece of the Puzzle
Recent studies in dogs suggest the gut microbiome may influence immune response and cancer outcomes. In research examining dogs receiving immunotherapy, survival appeared to vary depending on the composition of gut bacteria. The gut microbiome did not just affect digestion. It appeared to influence how effectively the immune system fought disease.
Nutramax Proviable-DC is the probiotic we use to support gut health, and the connection between a healthy microbiome and systemic longevity markers is one of the more compelling threads in current canine aging research.
Separately, researchers have been building out the first large-scale catalogs of canine gut bacteria, identifying strains never previously characterized in dogs. The field is moving quickly.
These are early-stage findings. The research shows associations, not confirmed causation, and practical recommendations for dog owners are not yet ready to be drawn from it. Researchers cannot yet tell you exactly which bacterial strains to cultivate in your dog’s gut or how to do it. What the research does suggest is that gut health is connected to more than digestion: immune function, disease resistance, and potentially cancer outcomes. Diet, fiber, and targeted probiotics are all ways to support the gut microbiome, and the growing body of research gives those choices additional weight, even while the science continues to develop.
We have a deeper look at how diet affects your dog’s digestive health in our guide to pumpkin for dogs and digestive problems. And if gut health has you thinking about what’s actually in your dog’s food, it is worth knowing how to check whether their food has been recalled.
What You Can Do Right Now
Multiple programs are in clinical trials and regulatory review. Availability depends on trial outcomes and FDA decisions. The gut microbiome science is accelerating. But most dog owners are asking a more immediate question: what can I actually do today?
The evidence base for extending dog lifespan through lifestyle is stronger than most people realize.
Maintain a healthy weight. One of the most impactful, evidence-supported steps most dog owners can take is keeping their dog lean. Long-term studies in dogs, including notable research in Labrador Retrievers, have found that maintaining a lean body condition is associated with meaningfully longer lifespan and delayed onset of chronic disease. That is a significant portion of a dog’s lifespan, and it is entirely addressable. If your dog is carrying extra weight, getting it off is the highest-leverage longevity intervention available right now.
Prioritize dental care. Periodontal disease is extremely common in dogs and drives chronic systemic inflammation. That inflammation is hard on the heart, kidneys, and immune system over time. Regular brushing, dental chews that actually work, and professional cleanings when needed have a real downstream effect on overall health.
We use Nutramax Welactin 3 Canine Omega-3 with both dogs as part of our approach to reducing chronic low-grade inflammation, which the longevity research consistently identifies as one of the primary drivers of biological aging.
Get bloodwork done annually. For dogs under 7, once a year. For senior dogs, twice a year. Kidney disease, thyroid issues, early diabetes, and early cancer markers can all be caught and managed far more effectively when detected early. By the time symptoms show up, organ damage is often already significant. Hazel’s kidney disease was diagnosed at 11 months, early enough that we could intervene aggressively. That intervention bought her years.
Keep the brain working. Canine cognitive dysfunction is real. Dogs experience something similar to dementia in old age, and mental stimulation (puzzle feeders, new environments, training games) appears to slow cognitive decline. A tired dog is not the same as a mentally engaged dog.
Ask your vet about longevity research. If you have a senior dog, ask whether any current studies or off-label options, including rapamycin research, are worth discussing for your dog’s specific situation. Your vet should be aware of the Dog Aging Project. If they are not, that is useful information too.
This Is the Beginning, Not the End
Dog longevity science is where human longevity science was about a decade ago: early, exciting, and moving fast. The drugs are real. The research is real. The FDA filings are real. What is also real is that none of this is available yet in the way that will eventually matter most.
The best thing you can do right now is take care of the fundamentals: weight, food quality, dental health, regular vet visits, and a gut microbiome you are paying attention to. These things do not require a clinical trial. The science on all of them is already settled.
We carry Spot Pet Health Insurance for both dogs, and having that coverage in place has made it easier to pursue the diagnostics and early interventions that the longevity science identifies as highest-impact.
The Daily Dog earns commissions from qualifying purchases through affiliate links. We only recommend products we have personally used with Hazel or Kaia and clearly note what has helped them.
The drugs that extend healthy lifespan may become available in the future, depending on trial outcomes and FDA review. The years you give your dog through good care are available today. They are worth every moment.
Last updated: February 2026
This article is for educational purposes only and does not provide veterinary or medical advice. Drug development and regulatory status can change; information is current as of February 2026. Rapamycin is not FDA-approved for longevity use in dogs; any use is off-label and must be evaluated and monitored by a licensed veterinarian. This article is not affiliated with or endorsed by Loyal, the Dog Aging Project, or any pharmaceutical company. We do not receive compensation from any company mentioned in this article; if that ever changes, it will be disclosed. If your dog is sick or you are considering any medication, consult your veterinarian.
Tyler Tilton
I do not write surface-level dog advice. When our dog got sick, I learned the hard way that most of what is out there is recycled, watered down, or just wrong. I started The Daily Dog to be the resource I could not find, the one that goes deeper, asks harder questions, and gives you the full picture so you can make real decisions for your dog.
